Cannabichromevarin or CBCV (also known as cannabivarichromene) is one of over a 100 variants of cannabinoid chemical compounds that act on cannabinoid receptors. CBCV is a phytocannabinoid found naturally in cannabis, and is a propyl cannabinoid and an effective anticonvulsant and used to treat brain cancer and epilepsy. The compound CBCV is within the patent US9084771 
3D model (JSmol)
CompTox Dashboard (EPA)
|Molar mass||286.415 g·mol−1|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
With a Molecular Formula: C19H26O2, and IUPAC Chemical Name of 2-methyl-2-(4-methylpent-3-enyl)-7-propylchromen-5-ol , Cannabichromevain has a molecular weight of 286.4 g/mol, CBCV is not thought to be psychoactive or impairing in any way, and is believed to be safe for children and adults and is a compound found in medical marijuana.
- "(±)-Cannabichromevarin (CRM) (CAS 41408-19-9)". www.caymanchem.com. U.S.: Cayman Chemical Company. Retrieved 2019-12-23.
- PubChem. "Cannabichromevarin". pubchem.ncbi.nlm.nih.gov. U.S. National Library of Medicine, National Institutes of Health. Retrieved 2019-12-23.
- "United States Patent: 9084771 - Methods and compositions for treating cancer".
- "What is Cannabichromevarin - CBCV? | Ionization Labs".